Who manufactures Votrient?
GlaxoSmithKline [NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved Votrient™ (pazopanib) to treat patients with advanced renal cell carcinoma (RCC), a form of kidney cancer.
What is the brand name for pazopanib?
Pazopanib is the generic name for the trade drug Votrient. In some cases, health care professionals may use the trade name votrient when referring to the generic drug name Pazopanib.
Is pazopanib FDA approved?
FDA Approval for Votrient (Pazopanib) for Advanced Soft Tissue Sarcoma. The Food and Drug Administration has approved the use of pazopanib (Votrient, made by GlaxoSmithKline) for the treatment of patients with advanced soft tissue sarcoma who have received prior chemotherapy.
Is there a generic for Votrient?
Votrient generic or biosimilar It’s not currently available in generic form. A generic drug is an exact copy of the active drug in a brand-name medication. Generics usually cost less than brand-name drugs. Votrient contains the active drug pazopanib.
Who makes sunitinib?
Sunitinib is marketed by Pfizer as Sutent, and is subject to patents and market exclusivity as a new chemical entity until February 15, 2021.
Is votrient covered by Medicare?
Do Medicare prescription drug plans cover Votrient? Yes. 100% of Medicare prescription drug plans cover this drug.
Is pazopanib an immunotherapy?
by Drugs.com Votrient is not an immunotherapy medicine. It is known as a targeted drug therapy and is used to treat cancer.
When was votrient FDA approved?
Development Timeline for Votrient
| Date | Article |
|---|---|
| Apr 26, 2012 | Approval FDA Approves Votrient for Advanced Soft Tissue Sarcoma |
| Oct 19, 2009 | Approval FDA Approves GlaxoSmithKline’s Votrient for Advanced Renal Cell Cancer |
| Oct 5, 2009 | GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for Votrient |
How long can you stay on pazopanib?
The median time on pazopanib in these patients was 2.4 years with the longest duration of 3.7 years.
How long can I take pazopanib?
You will usually carry on taking pazopanib for as long as it is working for you. Do not stop taking pazopanib without talking to your doctor first. If you have certain side effects, or changes in your blood test results, your doctor may tell you to stop taking pazopanib for a short time or to reduce the dose you take.
What is the brand name for sunitinib?
Sunitinib, sold under the brand name Sutent, is a medication used to treat cancer.
How much does sunitinib cost?
The price for a pack of 50-mg capsules (30 capsules per pack) is £3363.00 (excluding VAT; BNF edition 55). The average daily cost of sunitinib is £74.74, with an average 6-week cycle costing £3139.